Irillic

What Irillic does

Irillic Private Limited is an Indian med-tech company founded in 2019 and headquartered in Bangalore, Karnataka, that designs, develops, and manufactures Near-Infrared (NIR) fluorescence imaging systems for intraoperative surgical visualization. The company's core technology uses the Indocyanine Green (ICG) contrast agent to provide real-time visualization of tissue perfusion, lymphatic flow, and tumor margins, eliminating the radiation exposure associated with traditional radioisotope-based sentinel lymph node biopsy. Irillic's product portfolio comprises two flagship systems: the IRILLIC .nm, a handheld-probe fluorescence imaging system for open surgery featuring multiple color-augmented fluorescence modes and a 5-button remote probe interface, and the IRILLIC L.nm launched in November 2024 as India's first True 4K NIR laparoscopic imaging system, offering a modular 4K White / 4K NIR / 4K Open platform with 24-axis color calibration, Advanced Micro-Vascular Imaging (AMVI), and Intelliquant real-time quantification. Additional capabilities include NIR-based auto-fluorescence for parathyroid gland visualization during thyroid surgery, requiring no contrast agent.

Name

Irillic

Legal name

IRILLIC Private Limited

Website

https://irillic.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Imaging Hardware Systems: Irillic generates revenue primarily through the sale of fluorescence imaging hardware systems (Irillic .nm for open surgery and Irillic L.nm for laparoscopic surgery). These are capital equipment purchases with associated service and support contracts.
2. Service and Support: Ongoing service, maintenance, and support for installed imaging systems, likely including software updates and calibration services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Irillic designs, manufactures, and sells Near-Infrared (NIR) fluorescence imaging systems that use Indocyanine Green (ICG) contrast for real-time intraoperative visualization during surgical procedures. Its two flagship products — IRILLIC .nm for open surgery and IRILLIC L.nm for laparoscopic surgery — provide surgeons with visualization of tissue perfusion, lymphatic flow, tumor margins, and parathyroid auto-fluorescence across oncology, plastic/reconstructive surgery, head and neck surgery, and general/minimally invasive surgery applications. The systems are sold as capital equipment with associated service and support contracts to hospital surgical departments in India and select international markets.

Product overview

Irillic offers two flagship fluorescence imaging products: the IRILLIC .nm (Fluorescence Imaging System) for open surgery and the IRILLIC L.nm (Laparoscopy Imaging System) for minimally invasive surgeries. Both leverage Indocyanine Green (ICG) near-infrared fluorescence technology for real-time surgical visualization. The .nm system is a handheld probe-based platform for open procedures, while the L.nm is a modular True 4K+NIR system designed for laparoscopic integration. Together they address surgical oncology, plastic and reconstructive surgery, head and neck oncology, lymphedema screening, and general surgery applications across India's hospital network.

Differentiator

Problem solved

Functional benefit

Brands

• IRILLIC .nm: Fluorescence Imaging System for open surgery applications, featuring multiple color-augmented fluorescence modes and integrated patient management software.
• IRILLIC L.nm

Products and services

• IRILLIC .nm Fluorescence Imaging System designed for open surgery procedures, leveraging Indocyanine Green (ICG) and Near-Infrared (NIR) technology for real-time visualization of perfusion, lymphatics, and tissue viability. Features multiple color-augmented fluorescence modes, intuitive 5-button NIR remote probe interface, integrated patient management software, and intelligent background/anatomy light adjustment. Used by surgical oncologists, plastic/reconstructive surgeons, head and neck surgeons, and general surgeons in hospitals.
• IRILLIC L.nm India's first True 4K NIR laparoscopic imaging system for minimally invasive surgeries. Features a True 4K + NIR imaging chain with a complete modular platform supporting 4K White (standard laparoscopy), 4K NIR (fluorescence visualization), and 4K Open configurations. Includes 24-axis color calibration, Advanced Micro-Vascular Imaging (AMVI), a large-format image sensor, and Intelliquant for real-time quantification. Targeted at hospital surgical departments performing laparoscopic oncology, general surgery, gynecology, and gastroenterology procedures.

Quantifiable outcome

• ICG fluorescence shown to be as accurate as combined radiocolloid and blue dye for sentinel lymph node biopsy
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature10 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Intuitive Surgical: Intuitive Surgical's Firefly fluorescence imaging system, integrated into the da Vinci robotic surgery platform, is a direct peer in laparoscopic and robotic fluorescence-guided surgery. Comparable in target surgical use cases (laparoscopic cholecystectomy, colorectal, oncology) and represents the technology roadmap benchmark for Irillic L.nm.
• Stryker: Stryker (via its SPY-PHI / SPY Fluorescence Imaging platform, originally Novadaq) is the dominant global player in ICG-based intraoperative fluorescence imaging. Directly comparable to Irillic in core application (real-time perfusion, lymphatic mapping, sentinel node biopsy) and is the primary competitive benchmark Irillic positions against.

Broad incumbents

• Karl Storz: Karl Storz is a broad incumbent in endoscopy and integrated surgical visualization with NIR/ICG fluorescence capability (e.g., ICG mode in its IMAGE1 S and recent 4K platforms). Comparable as a competitor providing high-end white-light + NIR laparoscopic imaging systems to the same hospital surgical departments as Irillic L.nm.
• Medtronic: Medtronic is a broad incumbent offering surgical visualization and intraoperative imaging across laparoscopic and robotic-assisted platforms. Comparable as a diversified medtech player addressing surgical departments that adopt fluorescence imaging, with significantly larger installed-base reach than Irillic.
• Olympus Corporation: Olympus is a broad incumbent in surgical endoscopy and visualization with IR/NIR fluorescence imaging options on its VISERA 4K UHD and integrated OR1 platforms. Comparable to Irillic in combining 4K white-light with fluorescence for laparoscopic and open surgical applications across hospital systems.

Emerging players

• OnLume: OnLume is an emerging US-based surgical fluorescence imaging company developing NIR-guided visualization platforms for open and minimally invasive surgery. Comparable to Irillic's core NIR fluorescence approach but focused on US/EU markets and academic medical centers.
• Lumicell: Lumicell is an emerging US medtech company developing intraoperative fluorescence imaging systems for real-time cancer detection during breast cancer lumpectomy. Comparable to Irillic's surgical oncology use case (real-time margin and lymph node visualization) as a focused emerging competitor in fluorescence-guided oncologic surgery.
• FluoGuide: FluoGuide is an emerging player developing tumor-targeted fluorescent imaging agents (e.g., FG001) designed to be used with NIR imaging platforms during surgery. Comparable as an adjacent emerging participant in fluorescence-guided surgery, focused on agent rather than hardware, and therefore ecosystem-relevant to Irillic's installed base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@IRILLICINDIA
• LinkedInlinkedin.com/company/irillicindia
• Xx.com/irillic

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Irillic